摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2-二(二-2-吡啶基膦酰)乙烷 | 106308-26-3

中文名称
1,2-二(二-2-吡啶基膦酰)乙烷
中文别名
1,2-双(二-2-吡啶基膦)乙烷;2,2',2'',2'''-(1,2-乙二基二膦三基)四吡啶;1,2-双(二- 2 -吡啶基膦)乙烷
英文名称
1,2-Bis(di-pyridin-2-ylphosphino)ethane
英文别名
2,2',2'',2'''-(1,2-ethanediyldiphosphinidyne)tetrakispyridine;1,2-bis(bis(2-pyridyl)phosphine)ethane;1,2-bis[bis(2-pyridyl)phosphino]ethane;1,2-bis[di(2-pyridyl)phosphino]ethane;1,2-bis(di-2-pyridylphosphino)ethane;d2pype;1,2-Bis(di(pyridin-2-yl)phosphino)ethane;2-dipyridin-2-ylphosphanylethyl(dipyridin-2-yl)phosphane
1,2-二(二-2-吡啶基膦酰)乙烷化学式
CAS
106308-26-3
化学式
C22H20N4P2
mdl
——
分子量
402.375
InChiKey
GBLNXAZZONXIQE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    134-135 °C(Solv: acetone (67-64-1))
  • 沸点:
    576.7±45.0 °C(Predicted)
  • 稳定性/保质期:
    遵照规定使用和储存,则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    28
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    51.6
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2933399090
  • 储存条件:
    存于阴凉干燥处。

SDS

SDS:264729d73cbad74bc83d8fe2a99bb651
查看

Section 1: Product Identification
Chemical Name: 1,2-Bis(di-2-pyridylphosphino)ethane, min. 98%
CAS Registry Number: 106308-26-3
Formula: C22H20N4P2
EINECS Number: none
Chemical Family: organophosphine ligand
Synonym: 1,2-Bis(di-2-pyridylphosphano)ethane

Section 2: Composition and Information on Ingredients
Ingredient CAS Number Percent ACGIH (TWA) OSHA (PEL)
Title compound 106308-26-3 100% no data no data

Section 3: Hazards Identification
Emergency Overview: Irritating to skin, eyes and respiratory tract.
Primary Routes of Exposure: Inhalation, skin, eyes
Eye Contact: Causes slight to mild irritation of the eyes.
Skin Contact: Causes irritation to the skin
Inhalation: Causes irritation to the nose, mucous membranes and respiratory tract
Ingestion: No information on the physiological effects of ingestion. May be harmful if swallowed.
Acute Health Affects: Irritating to skin, eyes and respiratory tract.
Chronic Health Affects: No information available on long-term chronic effects
NTP: No
IARC: No
OSHA: No

SECTION 4: First Aid Measures
Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
Eye Exposure:
assistance in keeping their eye lids open. Get immediate medical attention.
Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
Skin Exposure:
irritation persists.
Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty
Inhalation:
in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce
Ingestion:
vomiting only if directed by medical personnel.

SECTION 5: Fire Fighting Measures
Flash Point: no data
Autoignition Temperature: no data
Explosion Limits: no data
Extinguishing Medium: carbon dioxide, dry chemical or foam
If this product is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure
Special Fire Fighting Procedures:
self-contained breathing apparatus and full protective clothing.
Hazardous Combustion and If involved in a fire, this material may emit irritating organic fumes
Decomposion Products:
Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards

SECTION 6: Accidental Release Measures
Small spills can be mixed with vermiculite, sodium carbonate or other suitable non-combustible adsorbent and
Spill and Leak Procedures:
swept up.

SECTION 7: Handling and Storage
Handling and Storage: Store the material in a tightly sealed container. Keep in a cool, dry place.

SECTION 8: Exposure Controls and Personal Protection
Eye Protection: Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection: Wear protective clothing and gloves.
Ventilation: Handle the material in an efficient fume hood.
If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator
Respirator:
Protection Program to be in compliance with 29 CFR 1910.134.
Ventilation: Handle the material in an efficient fume hood.
Additional Protection: No additional protection required.

SECTION 9: Physical and Chemical Properties
Color and Form: white powder
Molecular Weight: 402.37
Melting Point: no data
Boiling Point: no data
Vapor Pressure: no data
Specific Gravity: no data
Odor: none
Solubility in Water: insoluble

SECTION 10: Stability and Reactivity
Stability: air and moisture stable
Hazardous Polymerization: no hazardous polymerization
Conditions to Avoid: none
Incompatibility: oxidizing agents
Decomposition Products: carbon dioxide, carbon monoxide, phosphorus and nitrogen oxides and organic fumes

SECTION 11: Toxicological Information
RTECS Data: No information available in the RTECS files
Carcinogenic Effects: no data
Mutagenic Effects: no data
Tetratogenic Effects: no data

SECTION 12: Ecological Information
Ecological Information: No information available

SECTION 13: Disposal Considerations
Disposal: Dispose of according to local, state and federal regulations

SECTION 14: Transportation
Shipping Name (CFR): Non-hazardous
Hazard Class (CFR): NA
Additional Hazard Class (CFR): NA
Packaging Group (CFR): NA
UN ID Number (CFR): NA
Shipping Name (IATA): Non-hazardous
Hazard Class (IATA): NA
Additional Hazard Class (IATA): NA
Packaging Group (IATA): NA
UN ID Number (IATA): NA

SECTION 15: Regulatory Information
TSCA: Not listed in the TSCA inventory
SARA (Title 313): Title compound not listed
Second Ingredient: none


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    (1,5-cylooctadiene)di-iodoplatinum(II)1,2-二(二-2-吡啶基膦酰)乙烷二氯甲烷 为溶剂, 以46%的产率得到cis-PtI2(C2H4(P(C5H4N)2)2)
    参考文献:
    名称:
    Coordination Chemistry of the 2-Pyridyldiphosphine Ligands, (py)2P(CH(CH2)3CH)P(py)2 and (py)2P(CH2)2P(py)2 (py = 2-Pyridyl), with Platinum(II) and Ruthenium(II). Ruthenium-Catalyzed Hydrogenation of Imines
    摘要:
    The synthesis and characterization of a range of Pt(II) and Ru(II) complexes containing the new 2-pyridyldi-phosphine ligand, d(py)pcp = (py)(2)P(CH(CH2)(3)CH)P(py)(2) (made as a racemate) and the previously reported d(py)pe = (py)(2)P(CH2)(2)P(py)(2) are given (py =2-pyridyl). The Pt complexes made were cis-PtX2(d(py)pcp) (X = Cl (1), I (2)), cis-PtX2(d(py)pe) (X = Cl (3), I (4)), [Pt(d(py)pcp)(2)][PF6](2) (5), and [Pt(d(py)pe)(2)][PF6](2) (6); these all contain P,P-bonded diphosphine ligand, as evidenced by P-31 NMR data and by crystallographic data in the case of 2 and 3. The X-ray structure of d(py)pe is also reported. The complexes RuX2(P,P,N-d(py)pcp)(PPh3) have cis-halogens and a P,P,N-bonding mode of the pyridyldiphosphine (which incorporates a four-membered P,N-chelate ring) with either a mer-arrangement (in 7a, X = Cl) or a fac-arrangement of the three P donor atoms (in 7b (X = Cl), 8 (X = Br), 9 (X = I)); cis-RuCl2(dppb)(P,N-PPh2(py)) (12) (dppb = Ph-2(CH2)(4)PPh2) is included because it has a donor set corresponding to that in 7b. Use of the purely P,P donor Ph2P(CH(CH2)(3)CH)PPh2 (dppcp), made as a racemate, affords trans-RuCl2(dppcp)(2) (10) and trans-RuCl2(dppcp)(dppb) (II). Crystallographic data for 7a, 7b, and 12 are reported together with the NMR data for all the Ru complexes. Preliminary results show that the Ru complexes 7b, 8, and 9 are effective precursors for catalytic H-2-hydrogenation of aldimines.
    DOI:
    10.1021/ic990002o
  • 作为产物:
    参考文献:
    名称:
    Convenient synthetic routes to bidentate and monodentate 2-, 3- and 4-pyridyl phosphines: potentially useful ligands for water-soluble complex catalysts
    摘要:
    The monodentate and bidentate pyridyl phosphines, PR3 and R2P(CH2)(2)PR2, where R = 3- or 4-pyridyl can be prepared in high yields by treatment of butyllithium/TMEDA/3- or 4-bromopyridine with PCl3 or Cl2P(CH2)(2)PCl2 at low temperature. 1,2-Bis(di-2-pyridylphosphino)ethane is conveniently synthesised by an alternative route involving reaction of 1,2-dibromoethane with lithium di-2-pyridylphosphide. (C) 1998 Elsevier Science S.A. All rights reserved.
    DOI:
    10.1016/s0022-328x(97)00722-5
点击查看最新优质反应信息

文献信息

  • 2-Pyridyl-phosphine and -diphosphine complexes of nickel(0), their reactivity (including aqueous solution chemistry), and some related, incidental methylphosphonium iodides
    作者:Matthew D. Le Page、Brian O. Patrick、Steven J. Rettig、Brian R. James
    DOI:10.1016/j.ica.2015.04.003
    日期:2015.5
    Ni(CO)2[2H-d(py)pcp]}2+ being isolated as the bis(triflate) salt; the dication decomposes in minutes with formation of [Ni(H2O)6]2+, CO, the phosphine dioxide, and deprotonated d(py)pcp. Some twenty-two Ni0 complexes, exemplified by Ni(P–P)2, Ni(PNx)2(P–P), Ni(PNx)4, and related PPh3- and Ph2P(CH2)2PPh2 (dppe)-containing species, are synthesized from Ni(1,5-COD)2 and their reactivity studied; for
    摘要Ni(CO)2L2型Ni0-二羰基(吡啶基膦)配合物的化学性质,其中L为P键结合的PPh3-npyn(n = 1-3,py = 2-吡啶基;缩写为PNx,x = 1– 3,1a–c)或L2是(P–P)螯合的py2P(CH2)2Ppy2或,是我们小组从较早的研究中进一步开发的[P–P配体分别缩写为d(py) pe和d(py)pcp]。由Ni(CO)2(PPh3)2的C6H6溶液合成配合物,并检测到Ni(CO)2(PPh3)(PNx)中间体(1a ∗ –c ∗);X射线分析表明Ni(CO)2 [d(py)pcp](2b)具有扭曲的四面体结构;从CDCl3溶液中的光诱导反应中分离出NiII物质[Ni2(CO)4(μ-PN2)2] Cl4。络合物2b在环境条件下通过吡啶基N原子的净双质子化作用溶于水,分离出Ni(CO)2 [2H-d(py)pcp]} 2+为双(三氟甲磺酸盐)盐;指示剂在几分钟内分解,形成[Ni(H2O)6]
  • Certain bis(di-2 or 4-pyridyl-phosphino) alkanes #10 having anti-tumor
    申请人:Smithkline Beckman Corporation
    公开号:US04716230A1
    公开(公告)日:1987-12-29
    Heterocyclic phosphine compounds, pharmaceutical compositions containing an effective, tumor cell growth-inhibiting amount of such a compound, and a method for treating tumor cells sensitive to such a compound which comprises administering a tumor cell growth-inhibiting amount of such a compound to an animal afflicted by said tumor cells.
    含有有效的抗肿瘤细胞生长成分的杂环膦化合物,含有这种化合物的药物组合物,以及一种治疗对这种化合物敏感的肿瘤细胞的方法,包括向患有该肿瘤细胞的动物施用抗肿瘤细胞生长成分。
  • [Ni(Et<sub>2</sub>PCH<sub>2</sub>NMeCH<sub>2</sub>PEt<sub>2</sub>)<sub>2</sub>]<sup>2+</sup> as a Functional Model for Hydrogenases
    作者:Calvin J. Curtis、Alex Miedaner、Rebecca Ciancanelli、William W. Ellis、Bruce C. Noll、M. Rakowski DuBois、Daniel L. DuBois
    DOI:10.1021/ic020610v
    日期:2003.1.1
    ligand in the proton exchange reactions observed for the various Ni complexes containing the PNP ligand. Similarly, structural studies of [Ni(PNBuP)(2)](BF(4))(2) and [Ni(PNP)(dmpm)](BF(4))(2) (where PNBuP is Et(2)PCH(2)N(Bu)CH(2)PEt(2) and dmpm is Me(2)PCH(2)PMe(2)) illustrate the importance of tetrahedral distortions about Ni in determining the hydride acceptor ability of Ni(II) complexes.
    Et(2)PCH(2)N(Me)CH(2)PEt(2)(PNP)与[Ni(CH(3)CN)(6)](BF(4))(2)的反应结果在[Ni(PNP)(2)](BF(4))(2)的形成中,它同时具有氢化物和质子受体位点。该络合物是用于将氢氧化为质子的电催化剂,与氢的化学计量反应形成[HNi(PNP)(PNHP)](BF(4))(2),其中氢化物配体与Ni和质子键合与一个PNP配体的N侧基相连。使用热力学循环,与该反应有关的自由能已计算为-5 kcal / mol。氢化物配体和NH质子相互之间进行快速分子内交换,并与溶液中的质子进行分子间交换。[HNi(PNP)(PNHP)](BF(4))(2)经历可逆的去质子化反应,在乙腈溶液中形成[HNi(PNP)(2)](BF(4))(pK(a)= 10.6)。一种方便的合成方法来合成这种氢化物的PF(6)(-)盐包括PNP与Ni(COD)(2)反应形成N
  • NMR and structural studies of gold(I) chloride adducts with bidentate 2-, 3- and 4-pyridyl phosphines
    作者:Susan J. Berners-Price、Richard J. Bowen、Trevor W. Hambley、Peter C. Healy
    DOI:10.1039/a809285k
    日期:——
    The 12 adducts of gold(I) chloride with the diphosphine ligands, 1,2-bis(di-n-pyridylphosphino)ethane (dnpype) for n = 2, 3 and 4 have been synthesized and solution properties characterized by NMR spectroscopy, including variable temperature one dimensional 31P1H} and 2D [31P, 31P] COSY experiments. The results show the 3-pyridyl (d3pype) and 4-pyridyl (d4pype) adducts to exist as bis-chelated monomeric
    所述的金1个02加合物(我)氯化物与二膦配体,1,2-双(二- Ñ -pyridylphosphino)乙烷(d Ñ pype)为Ñ  = 2,3和4已被合成和溶液性质的特征在于NMR光谱学,包括可变温度一维31 P 1 H}和2D [ 31 P,31 P] COZY实验。结果显示3-吡啶基(d3pype)和4-吡啶基(d4pype)加合物以双螯合单体[Au(d3pype)2 ] +和[Au(d4pype)2 ] +的形式存在,而2-吡啶基(d2pype)加合物形成单体[Au(d2pype)的平衡混合物2 ] +,二聚体[Au(d2pype) 2 } 2 ] 2+和可能的四聚体[Au(d2pype) 2 } 4 ] 4+物种,其中d2pype配体通过磷原子在桥联和螯合模式下进行配位。存在的物质的相对百分比取决于温度和溶剂。由乙醇/己烷制得的4-吡啶基加合物的单晶X射线结构测定表明,该配合物结晶为[Au(d4pype)
  • A novel coordination mode for a pyridylphosphine ligand. X-ray structures of [RuCl<sub>2</sub>(NO)L] (<b>I</b>) and [RuCl<sub>2</sub>(NO)L]·DMSO (<b>II</b>) (L = [(2-py)<sub>2</sub>PC<sub>2</sub>H<sub>4</sub>POO(2-py)<sub>2</sub>]<sup>-</sup>)
    作者:Alzir A Batista、Salete L Queiroz、Peter C Healy、Robbie W Buckley、Sue E Boyd、Susan J Berners-Price、Eduardo E Castellano、Javier Ellena
    DOI:10.1139/v01-038
    日期:2001.5.1

    The ruthenium(II) complex, [RuCl2(NO)L] (I), (L = [(2-py)2PC2H4PO2(2-py)]-) was obtained from recrystallization of RuCl3NO(d2pype) (d2pype = (2-py)2PC2H4P(2-py)2) in the presence of HNO3, crystallizing in the monoclinic space group P21 (no. 4), with a = 8.012(4) Å, b = 14.454(4) Å, c = 9.353(3) Å, β = 105.77(3)°, and Z = 2. Crystals of the DMSO solvate of the complex (II) were obtained from (CD3)2SO solution, crystallizing in the monoclinic space group P21/c (no.14) with a = 9.7080(2) Å, b = 22.2920(5) Å, c = 11.5230(3) Å, β = 92.0450(10)°, and Z = 4. In both complexes, the geometry about the ruthenium atom is a distorted octahedron mainly as a result of the tridentate [P,N,O]-bonding mode of L. The ν (NO) bands at 1875 cm–1 in both complexes are consistent with the linear disposition of the NO group and the Ru atom as is observed in the X-ray crystal structure (Ru-N1-O1 angle = 178.5(4)°).Key words: pyridylphosphine, nitrosyl, ruthenium complex, X-ray structure.

    [RuCl2(NO)L] (I)是一种钌(II)配合物,其中L = [(2-py)2PC2H4PO2(2-py)]-,通过RuCl3NO(d2pype)(其中d2pype = (2-py)2PC2H4P(2-py)2)在HNO3存在下重结晶而得,晶化于单斜晶系空间群P21(no. 4),晶胞参数为a = 8.012(4) Å,b = 14.454(4) Å,c = 9.353(3) Å,β = 105.77(3)°,Z = 2。配合物的DMSO溶剂化物(II)的晶体通过(CD3)2SO溶液得到,晶化于单斜晶系空间群P21/c (no.14),晶胞参数为a = 9.7080(2) Å,b = 22.2920(5) Å,c = 11.5230(3) Å,β = 92.0450(10)°,Z = 4。在两种配合物中,钌原子周围的几何结构为畸变的八面体,主要是由于L的三齿配位方式[P,N,O]。两种配合物中的ν(NO)带位于1875 cm–1,与NO基团和Ru原子的线性排列与X射线晶体结构中观察到的Ru-N1-O1角度为178.5(4)°一致。关键词:吡啶膦,亚硝基,钌配合物,X射线结构。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-